肺癌介入治疗临床研究进展  

Recent progress in clinical application of interventional therapy for lung cancer

作　　者：黄坤林 刘玉金[1] HUANG Kunlin;LIU Yujin(Department of Interventional Oncology,Affiliated Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China)

机构地区：[1]上海中医药大学附属岳阳中西医结合医院肿瘤介入科

出　　处：《介入放射学杂志》2019年第10期1005-1008,共4页Journal of Interventional Radiology

摘　　要：肺癌是我国发病率和致死率第一位的恶性肿瘤,手术切除根治率低。进展期肺癌术后也容易复发和转移。占肺癌85%以上的非小细胞肺癌(NSCLC)对静脉化疗和放疗不敏感,且不良反应使患者拒绝接受或难以耐受。介入治疗已成为无法外科手术切除的NSCLC行之有效的治疗手段,具有微创、疗效满意、不良反应小、术后恢复快、节省治疗费用等优点。该文对肺癌的介入治疗方法及现状作一文献综述。Lung cancer is the number one malignant tumor with highest morbidity and mortality in China,and its radical resection rate is low.Advanced lung cancer is prone to recurrence and metastasis after surgery.Non-small-cell lung cancer(NSCLC),which accounts for more than 85%of all lung cancers,is insensitive to intravenous chemotherapy and radiotherapy,and due to the adverse reactions of chemotherapy and radiotherapy the patients often refused to accept these therapies or were difficult to tolerate the adverse response to chemotherapy and radiotherapy.At present,interventional therapy has become an effective treatment for inoperable NSCLC.Interventional therapy has the advantages of minimally invasive,satisfactory curative effect,less adverse reaction,quick recovery after operation,lower medical cost,etc.This article reviews the various methods and present situation of interventional therapy for lung cancers.(J Intervent Radiol,2019,28:1005-1008)

关 键 词：支气管肺癌 介入放射学 动脉灌注化疗 栓塞 消融 近距离放疗 放射性粒子125I 

分 类 号：R734[医药卫生—肿瘤]